Dr. Patrick Parfrey
Fellow
Current Employer
Memorial University of Newfoundland
Election Year
2009
Academy
Académie des sciences
Discipline
Medical Sciences
Department
Patient Research Centre
Keywords
Clinical epidemiology, clinical trials, health services
Dr. Patrick Parfrey is an international authority on the clinical epidemiology of kidney and genetic diseases. His research has had a global impact on the management of patients with kidney disease. He has lead or collaborated in national/international interdisciplinary teams that have determined the molecular genetic basis of several important diseases.
------------------
PARFREY, Patrick –Patient Research Centre, Memorial University
Dr. Patrick Parfrey is an international authority on the clinical epidemiology of kidney and genetic diseases. His research has had a global impact on the management of cardiac disease in chronic kidney disease, treatment modality in end-stage kidney disease, hepatitis in end-stage kidney disease; contast media induced acute kidney disease, and inherited cystic diseases of the kidney. He has lead or collaborated in national/international interdisciplinary research teams that have determined the molecular genetic basis of renal cystic diseases, arrhythmogenic cardiomyopathy and colorectal cancer. Also he has provided evidence to the Government of Newfoundland and Labrador that changed multiple health-care delivery policies.
------------------
PARFREY, Patrick –Patient Research Centre, Memorial University
Dr. Patrick Parfrey is an international authority on the clinical epidemiology of kidney and genetic diseases. His research has had a global impact on the management of cardiac disease in chronic kidney disease, treatment modality in end-stage kidney disease, hepatitis in end-stage kidney disease; contast media induced acute kidney disease, and inherited cystic diseases of the kidney. He has lead or collaborated in national/international interdisciplinary research teams that have determined the molecular genetic basis of renal cystic diseases, arrhythmogenic cardiomyopathy and colorectal cancer. Also he has provided evidence to the Government of Newfoundland and Labrador that changed multiple health-care delivery policies.
3637